| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/09/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Exercise | Common Stock Warrent | 60.2k | $3.88 | $233.3k | see footnote | 10/09/2014 |
| 10/09/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Disposition | Common Stock | 9.8k | $23.89 | $233.4k | see footnote | 10/09/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Exercise | Common Stock Warrant | 243 | $3.88 | $942.6 | See Footnote | 05/14/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Exercise | Common Stock Warrant | 64.9k | $3.88 | $251.8k | See Footnote | 05/14/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Disposition | Common Stock | 46 | $20.60 | $947.5 | See Footnote | 05/14/2014 |
| 05/14/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Disposition | Common Stock | 12.2k | $20.60 | $251.8k | See Footnote | 05/14/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 89.3k | $3.88 | $346.4k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Warrants to Purchase Series D Convertible Preferred Stock | 401.8k | $0.86 | $346.4k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 167.9k | $3.88 | $651.2k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Warrants to Purchase Series D Convertible Preferred Stock | 755.5k | $0.86 | $651.2k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 58.7k | $3.88 | $227.6k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Warrants to Purchase Series C Convertible Preferred Stock | 264k | $0.86 | $227.6k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 59.5k | $3.88 | $230.9k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Warrants to Purchase Series C Convertible Preferred Stock | 267.9k | $0.86 | $230.9k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock Warrant | 65.2k | $3.88 | $252.8k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Warrants to Purchase Series C Convertible Preferred Stock | 293.2k | $0.86 | $252.8k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series E Convertible Preferred Stock | 1.1M | $0.00 | $0 | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series D Convertible Preferred Stock | 11.8M | $0.00 | $0 | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series C Convertible Preferred Stock | 7.5M | $0.00 | $0 | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Series B Convertible Preferred Stock | 2.3M | $0.00 | $0 | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Purchase | Common Stock | 82.5k | $12.00 | $989.7k | See Footnote | 02/10/2014 |
| 02/10/2014 | Auspex Pharmaceuticals, Inc. | ASPX | Conversion | Common Stock | 5M | $0.00 | $0 | See Footnote | 02/10/2014 |